801695

Albert W. Schreiner III — FEI 3009705314

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 28, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cincinnati, OH (United States)

Additional Details

Clinical Investigator (CI)